• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

HIV – Markets for Diagnostics and Therapeutics

$2,995.00 – $6,995.00

Clear
SKU: KLI1646600 Category: Pharmaceuticals Market Research Pages: 250
  • Description
  • Table of Contents
  • Latest reports

Description

The strategic concept of HIV/AIDS diagnosis and therapy is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS diagnostics and therapeutics, companies must think on a global basis. In addition to the basic pathology and complications of HIV/AIDS, there are primarily three focal points for the development of strategy in this area: potential market, epidemiology (HIV/AIDS patient trends) and technology.

In his report HIV Markets for Diagnostics and Therapeutics, anlayst Kenneth Krul, PhD examines these focal points, with an eye to creating a comprehensive look at the market and opportunity for both testing and treatments of HIV. Dr. Krul takes a look at the potential theoretical markets and what will be realistic in the current world healthcare system.

The report contains extensive epidemological statistics for HIV in the following WHO health regiions:

  • Sub-Saharan Africa
  • Middle East and North Africa
  • South and South-East Asia
  • East Asia
  • Latin America
  • Caribbean
  • Eastern Europe and Central Asia
  • Western and Central Europe
  • North America
  • Oceania

In addition the report contains:

  • Current Market Sizes for HIV Treatments and Diagnostics in each WHO Health Region (treatment and diagnostic markets)
  • Profiles of Companies in this Market
  • Eleven Important Conclusions
  • Review of Current Treatment Products and Diagnostic Tools.

As with all Kalorama Information reports, this product is the result of primary and secondary research. Interviews with experts, as well as research into company reports, medical literature and government data is included.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Potential and Realistic Markets
  • Figure 1-1: “Theoretical” Distribution of HIV Market
  • Figure 1-2 Realistic Market for HIV/AIDs Diagnostics
  • Table 1-1: Global Market for HIV/AIDS Diagnostics and Therapeutics: 2008
  • Table 1-3: Regional HIV/AIDS Statistics: 2001 and 2007
  • Technology
  • Key HIV/AIDS Market Issues
  • Scope and Methodology

CHAPTER TWO: INTRODUCTION AND EPIDEMIOLOGY

  • HIV/AIDS Complications
  • HIV/AIDS Epidemiology
  • Table 2-1: Global Summary of HIV/AIDS Populations: 2007 (Category, Average, Range)
  • Figure 2-1: Estimated People Living With HIV/AIDS Globally: 1990 – 2007
  • Figure 2-2: Estimated Number of Adult and Child Deaths Due to AIDS Globally: 1990 – 2007
  • Figure 2-3: Estimated Incidence of HIV Infection Globally: 1990 – 2007 Sub-Saharan Africa
  • Table 2-2: Regional HIV/AIDS Statistics (I): 2001 and 2007 (Millions)
  • Table 2-3: Regional HIV/AIDS Statistics (II): 2001 and 2007
  • Figure 2-4: Estimated HIV Prevalence Rates (%) in Adults (15 – 49 Years) Globally and in Sub-Saharan Africa: 1990 – 2007
  • Table 2-4: Adult (Aged 14 – 49 years) HIV Prevalence in Sub-Saharan Countries That Have Recently Conducted Population-Based HIC Studies
  • Table 2-4 (continued): Adult (Aged 14 – 49 years) HIV Prevalence in Sub- Saharan Countries That Have Recently Conducted Population-Based HIC Studies
  • Asia
  • Eastern Europe and Central Asia
  • The Caribbean
  • Latin America
  • North America, Western and Central Europe
  • Figure 2-5: AIDS Distribution by Race in the United States: 2006
  • Figure 2-6: Risk Factors Associated with AIDS in Men in the United States: 2006
  • Table 2-5: Prevalence of HIV Infection in the United States Based on Sample Testing: 2006
  • Figure 2-5: AIDS Distribution by Race in the United States: 2006
  • Figure 2-6: Risk Factors Associated with AIDS in Men in the United States: 2006
  • Figure 2-7: Risk Factors Associated with AIDS in Women in the United States: 2006
  • The Middle East and North Africa

CHAPTER THREE: HIV/AIDS SCREENING AND DIAGNOSIS

  • Level 1: Screening
  • Level 2: Confirmatory Testing
  • Level 3: Diagnosis
  • Table 3-1: HIV Screening and Confirmatory Testing Products Approved for Use in the United States as of July 9, 2008
  • Table 3-2: Conditions Attributable to or Complicated by HIV
  • Table 3-3: AIDS Indicator Conditions
  • Level 4: Monitoring Treatment and Prognosis

CHAPTER FOUR: HIV/AIDS THERAPEUTICS

  • Drug Therapy
  • Figure 4-1: Binding of HIV to T-Cells
  • Table 4-1: HIV Entry/Fusion Inhibitors; FDA-Approved and in Development: 2008
  • Table 4-2: Nucleoside Reverse Transcription Inhibitors (NRTI); FDA-Approved and in Development: 2008
  • Table 4-3: Non-Nucleoside Reverse Transcription Inhibitors (NNRTI); FDA-Approved and in Development: 2008
  • Figure 4-3: HIV Integration
  • Table 4-4: Integrase Inhibitors; FDA-Approved and in Development: 2008
  • Figure 4-4: HIV Transcription
  • Figure 4-5: HIV Translation
  • Figure 4-6: HIV Assembly and Maturation
  • Table 4-5: Protease Inhibitors (PI)/Maturation Inhibitors (MI); FDA-Approved and in Development: 2008
  • Pediatric HIV/AIDS
  • Table 4-6: Anti-HIV Drugs in Development: 2008
  • Table 4-7: Anti-HIV Drugs Approved for Pediatric Use
  • Chemokine Therapeutics and HIV
  • Genes and HIV/AIDS
  • HIV/AIDS Vaccines

CHAPTER FIVE: MARKET ANALYSIS

  • Table 5-1: Estimated Theoretical Potential for HIV/AIDS Diagnostics and Therapeutics: 2008
  • Figure 5-1 HIV/AIDS Market by Major World Regions
  • Table 5-2: Global Market for HIV/AIDS Diagnostics and Therapeutics: 2008 Technology Key HIV/AIDS Market Issues

CHAPTER SIX: COMPANY SNAPSHOTS

  • Abbott Laboratories
  • Abbott Molecular Diagnostics
  • Bristol-Myers Squibb
  • Calypte Biomedical Corp.
  • Celera Diagnostics
  • Gen-Probe Incorporated
  • Gilead Sciences
  • GlaxoSmithKline plc
  • Luminex Corporation
  • QIAGEN GmbH
  • Roche Molecular Systems
  • Tibotec, Inc. (A Johnson & Johnson Company)
  • VIRxSYS Corporation

CHAPTER SEVEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS

  • First Conclusion
  • Second Conclusion
  • Third Conclusion
  • Fourth Conclusion
  • Fifth Conclusion
  • Sixth Conclusion
  • Seventh Conclusion
  • Eighth Conclusion
  • Ninth Conclusion
  • Tenth Conclusion
  • Eleventh Conclusion

CHAPTER EIGHT: GLOSSARY

    Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals
    May 22, 2023
    Precision Cancer Therapeutics Market, 2022
    October 25, 2022
    The World Market for Vaccines, 2022-2027
    September 23, 2022
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
    August 2, 2022

Related products

  • Placeholder image

    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    $2,246.00 – $4,492.00
  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00
  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Contract Manufacturing in Syringes, Catheters, Hip and Knee Implants, Air Pathways...The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis...
Scroll to top